ArticleJournal of nanobiotechnology2025
Bioengineered hollow nanoflowers to synergistically modulate inflammation, angiogenesis and osteogenesis for enhancing repair of bone defects.
Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundInadequate control of inflammation and insufficient vascularization remain major challenges in repair of bone defects. Here, we developed a multifunctional nanoflower, Au NPs@ZIF-8/Ga, by loading gallic acid (Ga) into a nanoflower-like structure consisting of gold nanoparticles (Au NPs) core and zeolitic imidazolate framework-8 (ZIF-8) shell, to synergistically exert anti-inflammatory, pro-angiogenic, and osteogenic effects.
resultsThe hollow architectures of the synthesized Au NPs@ZIF-8/Ga nanoflowers were characterized by transmission electron microscopy (TEM), energy-dispersive spectroscopy (EDS), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), and nitrogen adsorption-desorption analysis. In vitro studies demonstrated that Au NPs@ZIF-8/Ga reduced secretion of pro-inflammatory cytokines in macrophages via suppressing NF-κB pathway activation, while concurrently promoted endothelial cell migration, and tube formation. Yet, Au NPs@ZIF-8/Ga enhanced osteogenic differentiation of MC3T3-E1 cells, as evidenced by the upregulated expression of bone formation related genes runt-related transcription factor 2 (RUNX2) and osteocalcin (OCN), as well as increased alkaline phosphatase (ALP) activity and bone matrix mineralization. In vivo studies showed that Au NPs@ZIF-8/Ga promoted early resolution of inflammation, neovascularization and robust new bone formation in a rat model with critical-sized calvarial defects, as confirmed by Micro-computed tomography (micro-CT) and histological analyses.
conclusionCollectively, this work presents a versatile nanoplatform for reducing inflammation in early stage while subsequently promoting angiogenesis and osteogenesis, thereby offering a promising therapeutic strategy for bone regeneration under inflammatory conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.